The Problem: The Perceived Agile-GxP Conflict
Many pharma professionals believe agile and GxP compliance are fundamentally incompatible: agile embraces change while GxP demands control; agile minimizes documentation while GxP requires extensive evidence. This perceived conflict is based on a misunderstanding of both frameworks. Agile doesn't prohibit documentation — it prioritizes working software alongside necessary documentation. GxP doesn't require waterfall — it requires evidence that systems are fit for intended use.
The Solution: Practical Agile-GxP Patterns
- User Story Traceability: Each user story maps to URS requirements. Acceptance criteria double as test case specifications, creating traceability without separate artifacts.
- Sprint-Aligned Validation: IQ/OQ/PQ equivalents execute within the sprint delivering the functionality, not as a separate post-development phase.
- Living Documentation: Validation documents updated continuously, reviewed each sprint, baselined at release milestones.
- Automated Testing: Automated regression tests serve dual purpose — development QA and GxP validation evidence.
- Risk-Based Approach: Not all stories require the same validation rigor. Risk assessment determines depth, aligned with GAMP 5 principles.
The question is never "agile or GxP?" — it's "how do we design our agile process to produce the evidence GxP requires, as efficiently as possible?"
How ANG Associates Can Help
ANG Associates has implemented Agile-GxP best practices across multiple pharma clients. We train delivery teams in sprint-aligned validation techniques, design continuous documentation workflows, and establish the risk-based testing frameworks that make agile work in regulated environments. Our Scrum Masters and Project Managers speak both languages fluently — agile methodology and GxP compliance — ensuring your teams deliver fast without cutting compliance corners.